Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712704 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'PharmaVitae : Roche Global Analysis' returned 11 results - Page 1 of 1

  Sort by   
  Sorted by Rank Top-Bottom

F. Hoffmann-La Roche Ltd: PharmaVitae Profile  
Datamonitor, June 2011, Pages: 94
Roche financial outlook Key developments [Missing title] SWOT analysis ABOUT THIS PROFILE PharmaVitae Explorer database Chapter structure Strategic Insight Company


Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile  
Datamonitor, Nov 2010, Pages: 104
: PharmaVitae forecasts at a glance Strategic insight [Missing title] Chugai dominates the Japanese MAb landscape SWOT analysis Strengths Weaknesses Opportunities


F. Hoffmann-La Roche Ltd.: PharmaVitae Profile  
Datamonitor, July 2010, Pages: 117
prescription pharmaceutical sales by source ($m), 2003-15 Figure 17: Roche operating revenue/cost analysis ($m), 2003-15 F. Hoffmann-La Roche Ltd.: PharmaVitae Profile


Bayer AG: PharmaVitae Profile  
Datamonitor, June 2010
Schering Pharma: PharmaVitae forecasts at a glance Strategic insight Weak revenue performance initiates restructuring strategy in 2003 SWOT analysis Strengths Weaknesses


Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile  
Datamonitor, Oct 2009, Pages: 113
and competitors Data sourcing Sales data Analyst consensus Chapter 2 Executive summary Key findings Financial performance, 2002-14 Chugai: PharmaVitae forecasts at a glance Strategic insight The Roche


Genzyme Corporation  
Datamonitor, May 2011, Pages: 95
purchase agreement with Sekisui Chemical Phase III leukemia trial fails primary endpoint SWOT analysis Strengths Weaknesses Opportunities Threats ABOUT THIS PROFILE PharmaVitae


Bayer Schering Pharma AG: PharmaVitae Profile  
Datamonitor, June 2010, Pages: 116
Externalization analysis Chapter 6 Company financials Key findings Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2003-09 Operating costs and profit


Genentech Inc.: PharmaVitae Profile  
Datamonitor, March 2009, Pages: 148
: Genentech - PharmaVitae forecasts at a glance Table 2: Genentech quarterly global sales update ($m), Q4 2008 Table 3: Genentech key product developments, 2008 Table 4: Genentech product deals and alliances


Molecular Diagnostics: A Primer on an Emerging Sector  
Datamonitor, Nov 2008, Pages: 147
in this report 3 Figure 2: PharmaVitaes MDx classification scheme 4 Figure 3: The US vs. EU regulatory pathways 6 Figure 4: The IVD and MDx market size 2007 and 2013f 8 Figure 5: The key MDx tests 10 Figure 6


Big Pharma Mega-Mergers 1995-2014  
Datamonitor, Dec 2009, Pages: 114
-2014 Chapter 1 Introduction Scope of analysis Methodology Company coverage Data sources Re-creating analysis from this report using PharmaVitae Explorer queries Further reading Chapter 2 Executive


Monoclonal Antibodies Report: 2008 Update  
Datamonitor, June 2008, Pages: 363
strategic analysis of the mAb market out to 2013 - Global sales forecasts to 2013 for marketed and Phase III mAb products - Analysis of market trends by product, company, therapy area, technology and target


Results:  First -   Prev -   1 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds